Robuta

Sponsor of the Day: Jerkmate
https://www.sfb1709.de/ New Therapies for Myeloid Malignancies - SFB 1709 Apr 17, 2026 - Discover groundbreaking insights on Cellular Plasticity in Myeloid Malignancies and new therapies aimed at overcoming cancer resistance. new therapiesmyeloid malignanciessfb1709 https://www.kidney.org/news-stories/what-you-should-know-about-complement-3-glomerulopathy-c3g?page=1 Rare Kidney Disease C3G: Types, Diagnosis, and New Therapies | National Kidney Foundation C3G is a rare kidney disease with new treatments emerging. Learn the signs, types, therapies, and how research is driving hope for patients. rare kidney diseasetypes diagnosisnew therapiesnational foundationc3g https://news.cornell.edu/stories/2025/01/bacterial-changes-point-new-therapies-legionnaires-disease Bacterial changes point to new therapies for Legionnaires’ disease | Cornell Chronicle Researchers have pinpointed a key enzyme that allows Legionella to persist in the environment and in the body - and which could be used as a target for... new therapiescornell chroniclebacterialchangespoint https://stanmed.stanford.edu/innovations-returning-sight-glaucoma-patients/ New therapies show promise for restoring glaucoma patients’ vision Apr 22, 2026 - Ophthalmologists are testing eye implants, growth factors and gene therapy to protect optic nerves and slow glaucoma-related vision loss. new therapiesshow promiserestoringglaucomavision https://www.broadinstitute.org/how-broad-scientists-are-bridging-gap-between-biological-insights-and-new-therapies How Broad scientists are bridging the gap between biological insights and new therapies | Broad... At Broad’s Center for the Development of Therapeutics, biologists collaborate with drug-development experts to bring novel therapies to the clinic. biological insightsnew therapiesbroadscientistsbridging https://news.cornell.edu/stories/2026/04/discovery-could-lead-new-therapies-blood-disorders Discovery could lead to new therapies for blood disorders | Cornell Chronicle Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein; the discovery could lead to new therapies for blood... discovery could leadnew therapiesblood disorderscornell chronicle https://pharmaphorum.com/patients/providing-patient-access-new-therapies-dean-erhardt Providing patient access to new therapies, with Dean Erhardt | pharmaphorum Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow. patient accessnew therapiesprovidingdeanerhardt